New technology can detect melanoma cancer cells without a scalpel

May is Melanoma Awareness Month. One in five Americans develop skin cancer during their lifetime, and every hour of every day one American dies from melanoma. It’s not only one of the most common cancers diagnosed in the U.S., but also the deadliest of skin cancers. That's why early detection is so important. Dr. Ronald Moy introduces the new DermTech Pigmented Lesion Assay (PLA), a smart sticker applied to the surface of the skin that analyzes moles (in a non-invasive way, without a scalpel). The smart sticker has less than 1% chance of missing melanoma and is covered by Blue Cross, Blue Shield and Medicare.